CG Oncology, Correlations
| CGON Stock | 34.75 0.65 1.91% |
The current 90-days correlation between CG Oncology, Common and Patterson UTI Energy is -0.06 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CG Oncology, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CG Oncology, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
CG Oncology, Correlation With Market
Significant diversification
The correlation between CG Oncology, Common and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CG Oncology, Common and DJI in the same portfolio, assuming nothing else is changed.
CGON |
Moving together with CGON Stock
| 0.67 | ABBV | AbbVie Inc Sell-off Trend | PairCorr |
| 0.68 | AMGN | Amgen Inc | PairCorr |
| 0.61 | APGE | Apogee Therapeutics, | PairCorr |
Moving against CGON Stock
| 0.46 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
| 0.42 | VTRS | Viatris | PairCorr |
| 0.42 | ESPR | Esperion Therapeutics Buyout Trend | PairCorr |
| 0.31 | BCTXW | BriaCell Therapeutics | PairCorr |
| 0.56 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
| 0.42 | BSX | Boston Scientific Corp Sell-off Trend | PairCorr |
| 0.41 | EW | Edwards Lifesciences Corp | PairCorr |
Related Correlations Analysis
| 0.22 | 0.48 | 0.04 | 0.46 | 0.15 | -0.06 | PTEN | ||
| 0.22 | -0.4 | 0.71 | 0.29 | 0.86 | 0.19 | CQP | ||
| 0.48 | -0.4 | -0.52 | -0.38 | -0.6 | 0.13 | DTI | ||
| 0.04 | 0.71 | -0.52 | 0.51 | 0.78 | 0.26 | NRG | ||
| 0.46 | 0.29 | -0.38 | 0.51 | 0.48 | -0.19 | NBR | ||
| 0.15 | 0.86 | -0.6 | 0.78 | 0.48 | 0.16 | KNTK | ||
| -0.06 | 0.19 | 0.13 | 0.26 | -0.19 | 0.16 | SOC | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CGON Stock performing well and CG Oncology, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CG Oncology,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PTEN | 2.17 | (0.30) | 0.00 | (0.04) | 0.00 | 3.53 | 14.10 | |||
| CQP | 1.08 | 0.32 | 0.18 | 2.34 | 0.88 | 2.30 | 4.88 | |||
| DTI | 2.08 | (0.39) | 0.00 | (0.10) | 0.00 | 3.88 | 18.51 | |||
| NRG | 1.81 | 0.33 | 0.11 | 0.84 | 2.12 | 3.63 | 12.36 | |||
| NBR | 3.09 | (0.20) | 0.00 | (0.04) | 0.00 | 6.27 | 15.91 | |||
| KNTK | 1.48 | 0.44 | 0.22 | 0.74 | 1.30 | 3.19 | 11.51 | |||
| SOC | 4.06 | 0.79 | 0.12 | 3.94 | 5.18 | 6.52 | 60.69 |
CG Oncology, Corporate Management
| Bing Kung | Vice Development | Profile | |
| Joshua Patterson | General Officer | Profile | |
| Swapnil Bhargava | Chief Officer | Profile | |
| Vijay MD | Chief Officer | Profile |